In November 2022, the US Pharmacopeia (USP) released updates to their General Chapters on Compounding for sterile and non-sterile preparations that will go into effect on November 1, 2023. The question coming out of these updates is: how will they alter how I run my...
Daxxify is a new FDA-approved neuromodulator by Revance Therapeutics (“Revance”) designed to soften the look of fine lines and wrinkles. Daxxify differs from Botox and other botulinum toxin injectables, like Xeomin, Juveau, and Dysport, in that it is designed to work...
